Stock Events

Stock Events

BSF Enterprise 

$0.045180
3
-$0.00-0%Friday 20:00

Statistics

Day High
0.016
Day Low
0.016
52W High
0.0776
52W Low
0.0126
Volume
10,000
Avg. Volume
66
Mkt Cap
5.8M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-2,075.73%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
70,160.83Revenue
-1.46MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a major player in the biopharmaceutical industry, directly competing in the development and commercialization of medical therapies, similar to BSF Enterprise.
Merck
MRK
Mkt Cap368.89B
Merck operates in the pharmaceutical sector, focusing on innovative drug development which competes with BSF Enterprise's therapeutic projects.
Novartis
NVS
Mkt Cap303.67B
Novartis is known for its extensive research and development in healthcare, making it a direct competitor in the pharmaceutical and biotech fields.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson offers a broad range of health products, including pharmaceuticals, competing across several of BSF Enterprise's key areas.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline focuses on pharmaceuticals and vaccines, which aligns with BSF Enterprise's interests in drug development and medical treatments.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie is involved in biopharmaceutical research, directly competing with BSF Enterprise in the development of advanced therapies.
AMGEN
AMGN
Mkt Cap251.94B
Amgen specializes in human therapeutics, operating in an industry similar to BSF Enterprise's, particularly in innovative biological treatments.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb is engaged in the discovery, development, and delivery of medicines, similar to BSF Enterprise's operations.
Sanofi
SNY
Mkt Cap106.24B
Sanofi focuses on pharmaceuticals and treatments for various diseases, competing with BSF Enterprise in the healthcare solutions sector.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a powerhouse in pharmaceuticals and diagnostics, which places it in direct competition with BSF Enterprise in multiple therapeutic areas.

About

BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors.
Show More
CEO
Che John Connon
Employees
14
Country
United Kingdom
ISIN
GB00BHNBDQ51

Listings

OTC Link
US
BSFAF
LSE
GB
BSFA.LSE

0 Comments

Share your thoughts

FAQs

What is BSF Enterprise stock price today?▼
The current price of BSFAF is $0.05 USD — it has decreased by -0% in the past 24 hours. Watch BSF Enterprise stock price performance more closely on the chart.
What is BSF Enterprise stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BSF Enterprise stocks are traded under the ticker BSFAF.
Is BSF Enterprise stock price growing?▼
BSFAF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year BSF Enterprise has showed a -7.7% decrease.
What is BSF Enterprise market cap?▼
Today BSF Enterprise has the market capitalization of 5.8M
What is BSF Enterprise revenue for the last year?▼
BSF Enterprise revenue for the last year amounts to 70,160.83 USD.
What is BSF Enterprise net income for the last year?▼
BSFAF net income for the last year is -1.46M USD.
How many employees does BSF Enterprise have?▼
As of November 5, 2026, the company has 14 employees.
In which sector is BSF Enterprise located?▼
BSF Enterprise operates in the Health & Wellness sector.
When did BSF Enterprise complete a stock split?▼
The last stock split for BSF Enterprise was on December 18, 2025 with a ratio of 1:12.
Where is BSF Enterprise headquartered?▼
BSF Enterprise is headquartered in London, United Kingdom.